Name | Recombinant Mouse TGF-beta RII/(mouse) Fc Chimera, CF |
---|---|
Supplier | R&D Systems |
Catalog | 1600-R2 |
Category | Protein |
Prices | $349.00 |
Sizes | 50 µg |
Species Reactivities | Mouse |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Mouse TGF-beta RII (Ile24 - Asp184) Accession # Q62312 IEGRMDP Mouse IgG 2a (Glu98 - Lys330) N-terminus C-terminus |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by its ability to inhibit TGF-beta 1 activity on HT‑2 mouse T cells. Tsang, M. et al . (1995) Cytokine 7 :389. The ED 50 for this effect is 3-10 ng/mL in the presence of 1 ng/mL of rhTGF-beta 1. |
Endotoxin | <0.01 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | Q62312 |
Gene | Tgfbr2 |
Sequence | Ile24 |
Supplier Page | Shop |
Li Y, Wang J, Asahina K. Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2324-9.
Garidou L, Heydari S, Gossa S, McGavern DB. J Virol. 2012 Jul;86(13):7060-71.
Castonguay R, Werner ED, Matthews RG, Presman E, Mulivor AW, Solban N, Sako D, Pearsall RS, Underwood KW, Seehra J, Kumar R, Grinberg AV. J Biol Chem. 2011 Aug 26;286(34):30034-46.
Kissick HT, Ireland DJ, Beilharz MW. J Interferon Cytokine Res. 2009 Apr;29(4):209-15.
Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. Nat Med. 2007 Nov;13(11):1324-32. Epub 2007 Oct 21.